Terpenes: Substances Useful in Human Healthcare
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies1
Vol. 6, 3071–3080, August 2000 Clinical Cancer Research 3071 Phase I Pharmacokinetic Trial of Perillyl Alcohol (NSC 641066) in Patients with Refractory Solid Malignancies1 Gary R. Hudes,2 Christine E. Szarka, mononuclear cells obtained from patients treated at the Andrea Adams, Sulabha Ranganathan, highest dose level. The metabolites PA and DHPA did not ras Robert A. McCauley, Louis M. Weiner, change expression or isoprenylation of p21 in MCF-7 breast or DU145 prostate carcinoma cells at concentra- Corey J. Langer, Samuel Litwin, Gwen Yeslow, tions that exceeded those achieved in patient plasma after Theresa Halberr, Mingxin Qian, and POH treatment. We conclude that POH at 1600–2100 James M. Gallo mg/m2 p.o. three times daily is well tolerated on a 14-day Departments of Medical Oncology [G. R. H., C. E. S., S. R., R. A. M., on/14-day off dosing schedule. Inhibition of p21ras func- L. M. W., C. J. L., G. Y., T. H.], Pharmacology [A. A., M. Q., tion in humans is not likely to occur after POH adminis- J. M. G.], and Biostatistics [S. L.], Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 tration at safe doses of the present oral formulation. ABSTRACT INTRODUCTION Perillyl alcohol (POH) is a monoterpene with anti- The monoterpenes are a diverse class of isoprenoid carcinogenic and antitumor activity in murine tumor molecules derived from the anabolism of acetate by the models. Putative mechanisms of action include activation mevalonic acid branch biosynthetic pathways of plants. d- of the transforming growth factor  pathway and/or in- Limonene, a major component of orange peel oil and the hibition of p21ras signaling, leading to differentiation or prototype monoterpene in carcinogenesis studies, is formed apoptosis. -
Antiviral Activities of Oleanolic Acid and Its Analogues
molecules Review Antiviral Activities of Oleanolic Acid and Its Analogues Vuyolwethu Khwaza, Opeoluwa O. Oyedeji and Blessing A. Aderibigbe * Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa; [email protected] (V.K.); [email protected] (O.O.O) * Correspondence: [email protected]; Tel.: +27-406022266; Fax: +08-67301846 Academic Editors: Patrizia Ciminiello, Alfonso Mangoni, Marialuisa Menna and Orazio Taglialatela-Scafati Received: 27 July 2018; Accepted: 5 September 2018; Published: 9 September 2018 Abstract: Viral diseases, such as human immune deficiency virus (HIV), influenza, hepatitis, and herpes, are the leading causes of human death in the world. The shortage of effective vaccines or therapeutics for the prevention and treatment of the numerous viral infections, and the great increase in the number of new drug-resistant viruses, indicate that there is a great need for the development of novel and potent antiviral drugs. Natural products are one of the most valuable sources for drug discovery. Most natural triterpenoids, such as oleanolic acid (OA), possess notable antiviral activity. Therefore, it is important to validate how plant isolates, such as OA and its analogues, can improve and produce potent drugs for the treatment of viral disease. This article reports a review of the analogues of oleanolic acid and their selected pathogenic antiviral activities, which include HIV, the influenza virus, hepatitis B and C viruses, and herpes viruses. Keywords: HIV; influenza virus; HBV/HCV; natural product; triterpenoids; medicinal plant 1. Introduction Viral diseases remain a major problem for humankind. It has been reported in some reviews that there is an increase in the number of viral diseases responsible for death and morbidity around the world [1,2]. -
Phytochemicals
Phytochemicals HO O OH CH OC(CH3)3 3 CH3 CH3 H H O NH O CH3 O O O O OH O CH3 CH3 OH CH3 N N O O O N N CH3 OH HO OH HO Alkaloids Steroids Terpenoids Phenylpropanoids Polyphenols Others Phytochemicals Phytochemical is a general term for natural botanical chemicals Asiatic Acid [A2475] is a pentacyclic triterpene extracted from found in, for example, fruits and vegetables. Phytochemicals are Centella asiatica which is a tropical medicinal plant. Asiatic Acid not necessary for human metabolism, in contrast to proteins, possess wide pharmacological activities. sugars and other essential nutrients, but it is believed that CH3 phytochemicals affect human health. Phytochemicals are CH3 components of herbs and crude drugs used since antiquity by humans, and significant research into phytochemicals continues today. H C CH H C OH HO 3 3 O Atropine [A0754], a tropane alkaloid, was first extracted from H CH3 the root of belladonna (Atropa belladonna) in 1830s. Atropine is a HO competitive antagonist of muscarine-like actions of acetylcholine CH3 H and is therefore classified as an antimuscarinic agent. OH [A2475] O NCH3 O C CHCH2OH Curcumin [C0434] [C2302], a dietary constituent of turmeric, has chemopreventive and chemotherapeutic potentials against various types of cancers. OO CH3O OCH3 [A0754] HO OH Galantamine Hydrobromide [G0293] is a tertiary alkaloid [C0434] [C2302] found in the bulbs of Galanthus woronowi. Galantamine has shown potential for the treatment of Alzheimer's disease. TCI provides many phytochemicals such as alkaloids, steroids, terpenoids, phenylpropanoids, polyphenols and etc. OH References O . HBr Phytochemistry of Medicinal Plants, ed. -
Tryptophan | C11H12N2O2 - Pubchem
07.01.2021 Tryptophan | C11H12N2O2 - PubChem COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: https://www.coronavirus.gov. Get the latest research from NIH: https://www.nih.gov/coronavirus. COMPOUND SUMMARY Tryptophan PubChem CID 6305 Structure 2D 3D Crystal Find Similar Structures Chemical Safety Laboratory Chemical Safety Summary (LCSS) Datasheet Molecular Formula C11H12N2O2 L-tryptophan 73-22-3 tryptophan Synonyms L-Tryptophane (S)-Tryptophan More... Molecular Weight 204.22 g/mol Modify Create Dates 2021-01-02 2004-09-16 Tryptophan is the least plentiful of all 22 amino acids and an essential amino acid in humans (provided by food), Tryptophan is found in most proteins and a precursor of serotonin. Tryptophan is converted to 5-hydroxy-tryptophan (5-HTP), converted in turn to serotonin, a neurotransmitter essential in regulating appetite, sleep, mood, and pain. Tryptophan is a natural sedative and present in dairy products, meats, brown rice, fish, and soybeans. (NCI04) NCI Thesaurus (NCIt) Source: NCI Thesaurus (NCIt) Record Name: Tryptophan URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C29603 Description: NCI Thesaurus (NCIt) provides reference terminology for many systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities. License Note: Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source. License URL: https://www.cancer.gov/policies/copyright-reuse L-tryptophan is the L-enantiomer of tryptophan. It has a role as an antidepressant, a nutraceutical, a micronutrient, a plant metabolite, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. -
Process for the Preparation of Perillyl Alcohol
Europäisches Patentamt *EP001236802A1* (19) European Patent Office Office européen des brevets (11) EP 1 236 802 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: C12P 7/02, C12N 1/20, 04.09.2002 Bulletin 2002/36 C12N 1/21 // (C12P7/02, C12R1:06), (21) Application number: 01103785.0 (C12P7/02, C12R1:15), (22) Date of filing: 16.02.2001 (C12P7/02, C12R1:365), (C12P7/02, C12R1:32) (84) Designated Contracting States: • Witholt, Bernard AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU 8032 Zurich (CH) MC NL PT SE TR • Jourdat, Catherine Designated Extension States: 69110 Sainte Foy les Lyon (FR) AL LT LV MK RO SI (74) Representative: Mérigeault, Shona (71) Applicant: AVENTIS ANIMAL NUTRITION S.A. Aventis CropScience SA 92160 Antony (FR) Département Propriété Industrielle 14-20, rue Pierre Baizet, B.P. 9163 (72) Inventors: 69263 Lyon Cedex 09 (FR) • Duetz, Wouter Adriaan 8049 Zurich-Hongg (CH) (54) Process for the preparation of perillyl alcohol (57) The invention provides a process for the prep- cell, which microbial cell is capable of expressing a mo- aration of a hydroxymethylated terpene analog, for ex- nooxygenase capable of terminal hydroxylation of an n- ample (+) or (-) perillyl alcohol, which process comprises alkane. contacting a terpene analoog having a terminal methyl group, for example D- or L-limonene, with a microbial EP 1 236 802 A1 Printed by Jouve, 75001 PARIS (FR) EP 1 236 802 A1 Description Field of the invention 5 [0001] The present invention relates to a process for the preparation of a hydroxymethylated terpene analog from a terpene analog having a terminal methyl group, using a microbial cell or a lysate thereof. -
The Wonderful Activities of the Genus Mentha: Not Only Antioxidant Properties
molecules Review The Wonderful Activities of the Genus Mentha: Not Only Antioxidant Properties Majid Tafrihi 1, Muhammad Imran 2, Tabussam Tufail 2, Tanweer Aslam Gondal 3, Gianluca Caruso 4,*, Somesh Sharma 5, Ruchi Sharma 5 , Maria Atanassova 6,*, Lyubomir Atanassov 7, Patrick Valere Tsouh Fokou 8,9,* and Raffaele Pezzani 10,11,* 1 Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar 4741695447, Iran; [email protected] 2 University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore 54600, Pakistan; [email protected] (M.I.); [email protected] (T.T.) 3 School of Exercise and Nutrition, Deakin University, Victoria 3125, Australia; [email protected] 4 Department of Agricultural Sciences, University of Naples Federico II, 80055 Portici (Naples), Italy 5 School of Bioengineering & Food Technology, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India; [email protected] (S.S.); [email protected] (R.S.) 6 Scientific Consulting, Chemical Engineering, University of Chemical Technology and Metallurgy, 1734 Sofia, Bulgaria 7 Saint Petersburg University, 7/9 Universitetskaya Emb., 199034 St. Petersburg, Russia; [email protected] 8 Department of Biochemistry, Faculty of Science, University of Bamenda, Bamenda BP 39, Cameroon 9 Department of Biochemistry, Faculty of Science, University of Yaoundé, NgoaEkelle, Annex Fac. Sci., Citation: Tafrihi, M.; Imran, M.; Yaounde 812, Cameroon 10 Phytotherapy LAB (PhT-LAB), Endocrinology Unit, Department of Medicine (DIMED), University of Padova, Tufail, T.; Gondal, T.A.; Caruso, G.; Via Ospedale 105, 35128 Padova, Italy Sharma, S.; Sharma, R.; Atanassova, 11 AIROB, Associazione Italiana per la Ricerca Oncologica di Base, 35128 Padova, Italy M.; Atanassov, L.; Valere Tsouh * Correspondence: [email protected] (G.C.); [email protected] (M.A.); [email protected] (P.V.T.F.); Fokou, P.; et al. -
(12) United States Patent (10) Patent No.: US 9.271,949 B2 Hazan Et Al
US00927 1949B2 (12) United States Patent (10) Patent No.: US 9.271,949 B2 Hazan et al. (45) Date of Patent: Mar. 1, 2016 (54) COMPOSITIONS COMPRISING ACIDIC 2005/023874O A1 10/2005 Fotinos EXTRACTS OF MASTC GUM 2009/004.8205 A1 2/2009 Meyer 2014/0294928 A1 10/2014 Hazan et al. (75) Inventors: Zadik Hazan, Zichron Yaakov (IL); Andre C. B. Lucassen, Rehovot (IL) FOREIGN PATENT DOCUMENTS CN 1173134 A 2, 1998 (73) Assignee: REGENERA PHARMA LTD., EP 152O585 4/2005 Rehovot (IL) GR 1.003541 3, 2001 GR 10O3868 4/2002 JP 2007135493 6, 2007 (*) Notice: Subject to any disclaimer, the term of this WO 01.21212 A1 3, 2001 patent is extended or adjusted under 35 WO O3,O92712 11, 2003 U.S.C. 154(b) by 0 days. WO O3,O97212 11, 2003 WO 2005/094837 10/2005 (21) Appl. No.: 13/821,194 WO 2005/112967 12/2005 WO 2006/OO3659 1, 2006 WO 20080243.74 A2 2, 2008 (22) PCT Filed: Sep. 7, 2011 WO 2010030082 A2 3, 2010 WO 2010/100650 9, 2010 (86). PCT No.: PCT/L2O11AOOO724 WO 2010/100651 9, 2010 S371 (c)(1), (2), (4) Date: Mar. 6, 2013 OTHER PUBLICATIONS (87) PCT Pub. No.: WO2012/032523 CAS Registry record for “Masticadienoic Acid' (retrieved Aug. 2014).* PCT Pub. Date: Mar. 15, 2012 Al-Habbal, M.J., Al-Habbal, Z, Huwez, F.U. A double-blind con trolled clinical trial of mastic and placebo in the treatment of (65) Prior Publication Data duodenal ulcer, Clin Exp Pharmacol Physiol, 1984, 11. -
Perillyl Alcohol As a Bactericide and Yeasticide Perilla-Alkohol Als Bakterien- Und Hefenabtotendes Mittel Alcool Perillique Utilise Comme Bactericide Et Levuricide
Patentamt Europaisches |||| ||| 1 1|| ||| ||| || || || || ||| || |||| || (19) J European Patent Office Office europeen des brevets (11) EP 0 585 402 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publicationation and mention (51) |nt. CI.6: A01 N 31/00, A61 K 31/045 of the grant of the patent: 09.04.1997 Bulletin 1997/15 (86) International application number: PCT/US92/01008 (21) Application number: 92914522.5 (87) International publication number: (22) Date of filing: 07.02.1992 WO 93/15606 (19.08.1993 Gazette 1993/20) (54) PERILLYL ALCOHOL AS A BACTERICIDE AND YEASTICIDE PERILLA-ALKOHOL ALS BAKTERIEN- UND HEFENABTOTENDES MITTEL ALCOOL PERILLIQUE UTILISE COMME BACTERICIDE ET LEVURICIDE (84) Designated Contracting States: • DATABASE WPI Week 841 3, Derwent AT BE CH DE ES FR GB IT LI NL SE Publications Ltd., London, GB; AN 84-078371 [13] & JP-A-59 029 619 (HASEGAWA) 16 (43) Date of publication of application: February 1984 09.03.1994 Bulletin 1994/10 • DATABASE CHEMABS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US (73) Proprietor: CHASTAIN, Doyle, E. CA90(3):1 7664a Titusville, FL 32780 (US) • PATENT ABSTRACTS OF JAPAN vol. 1 6, no. 1 1 4 (C-921)(5157) & JP-A-03 287 597 (NIPPON Inventors: (72) TERUPEN KAGAKU) 18 December 1991 E. • CHASTAIN, Doyle, • O.-A. NEUMULLER 'Rompps Chemie-Lexikon' Titusville, FL 32780 (US) 1985 FRANCKH'SCHE VERLAGSHANDLUNG • SANDERS, Christine, C. , , STUTTGART, DE Band 4: M-Pk * page 3048, NB 68131 Omaha, (US) 'Perillaaldehydoxim' * • SANDERS, W., Eugene, Jr. • JOURNAL OF THE AMERICAN Omaha, NB 68131 (US) PHARMACEUTICAL ASSOCIATION. SCIENTIFIC EDITION vol. XLV, no. 6 June 1956 (74) Representative: Williams, John Francis et al , , WASHINGTON US 378 - 381 C.M.JASPER WILLIAMS, POWELL & ASSOCIATES pages ET AL. -
(12) United States Patent (10) Patent No.: US 7,615,546 B2 Gupta (45) Date of Patent: Nov
USOO761.5546B2 (12) United States Patent (10) Patent No.: US 7,615,546 B2 Gupta (45) Date of Patent: Nov. 10, 2009 (54) TOPICAL DELIVERY SYSTEM FOR 6,407,085 B1* 6/2002 Kief ........................... 514, 182 PHYTOSTEROLS * cited by examiner (75) Inventor: Shyam K Gupta, Scottsdale, AZ (US) Primary Examiner Shaojia Anna Jiang Assistant Examiner Eric S Olson (73) Assignee: BioDerm Research, Scottsdale, AZ (US) (57) ABSTRACT (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 This invention relates to certain Sugaresters of phytosterols of U.S.C. 154(b) by 0 days. formula (I). These esters are useful for topical application, and for the treatment of skin condition, including age spots, (21) Appl. No.: 12/210,266 acne, loss of cellular antioxidants, collagen loss, loss of skin pliability, loss of skin Suppleness, skin wrinkles including (22) Filed: Sep.15, 2008 fine lines, oxidation, damage from radiation, malfunction of matrix metalloproteases, malfunction of tyrosinases, damage (65) Prior Publication Data from free radicals, damage from UV, dry skin, Xerosis, ich US 2009/0042846A1 Feb. 12, 2009 thyosis, dandruff, brownish spots, keratoses, melasma, len tigines, liver spots, pigmented spots, dark circles under the Related U.S. Application Data eyes, skin pigmentation including darkened skin, blemishes, (63) Continuation-in-part of application No. 1 1/161,856, oily skin, warts, eczema, pruritic skin, psoriasis, inflamma filed on Aug. 19, 2005, now abandoned, and a continu tory dermatoses, topical inflammation, disturbed keratiniza ation-in-part of application No. 12/139,659, filed on tion, skin changes associated with aging, nail or skin requir ing cleansers, conditioning or treatment, and hair or scalp Jun. -
The Isoprenoid Alcohol Pathway, a Synthetic Route for Isoprenoid Biosynthesis
The isoprenoid alcohol pathway, a synthetic route for isoprenoid biosynthesis James M. Clomburga,b,1, Shuai Qiana,1, Zaigao Tana,1, Seokjung Cheonga,1, and Ramon Gonzaleza,b,2 aDepartment of Chemical and Biomolecular Engineering, Rice University, Houston, TX 77005; and bDepartment of Chemical and Biomedical Engineering, University of South Florida, Tampa, FL 33620 Edited by Tobias J. Erb, Max Planck Institute for Terrestrial Microbiology (MPG), Marburg, Germany, and accepted by Editorial Board Member Caroline S. Harwood May 15, 2019 (received for review December 13, 2018) The more than 50,000 isoprenoids found in nature are all derived limited product titers and yields to well below theoretical from the 5-carbon diphosphates isopentenyl pyrophosphate (IPP) maxima (3, 5). and dimethylallyl pyrophosphate (DMAPP). Natively, IPP and Opposed to working within the constraints of native metabo- DMAPP are generated by the mevalonate (MVA) and 2-C-methyl- lism, the development of synthetic metabolic pathways can ex- D-erythritol-4-phosphate (MEP) pathways, which have been engi- ploit the ever-expanding repertoire of biochemical reactions to neered to produce compounds with numerous applications. How- both improve attenable product titers and yields as well as confer ever, as these pathways are inherently constrained by carbon, novel biological capabilities for utilizing promising feedstocks energy inefficiencies, and their roles in native metabolism, engi- and the synthesis of non-natural products (7, 8). Here, we sought neering for isoprenoid biosynthesis at high flux, titer, and yield to develop de novo pathways for isoprenoid synthesis by exploiting remains a challenge. To overcome these limitations, here we de- enzymes and biochemical reactions beyond those involved in velop an alternative synthetic pathway termed the isoprenoid al- the MVA and MEP pathways. -
Aldrich Alcohols and Phenols
Aldrich Alcohols and Phenols Library Listing – 1,200 spectra Subset of Aldrich FT-IR Library related to alcohols and phenols. The Aldrich Material-Specific FT-IR Library collection represents a wide variety of the Aldrich Handbook of Fine Chemicals' most common chemicals divided by similar functional groups. These spectra were assembled from the Aldrich Collection of FT-IR Spectra and the data has been carefully examined and processed by Thermo. The molecular formula, CAS (Chemical Abstracts Services) registry number, when known, and the location number of the printed spectrum in The Aldrich Library of FT-IR Spectra are available. Aldrich Alcohols and Phenols Index Compound Name Index Compound Name 306 ((1S)-ENDO)-(-)-BORNEOL, 99% 310 (1S,2S,3S,5R)-(+)- 1044 (+)-(4,6-O-BENZYLIDENE)METHYL- ISOPINOCAMPHEOL, 98% ALPHA-D- GLUCOPYRANOSIDE, 351 (2-ENDO, 3-EXO)-5-NORBORNENE- 97% 2,3- DIMETHANOL 1042 (+)-2,3-O-BENZYLIDENE-D- 355 (2-ENDO,3-EXO)- THREITOL, 99% BICYCLO(2.2.2)OCT-5-ENE- 2,3- 528 (+)-ARABINOGALACTAN DIMETHANOL, 96% 305 (+)-BORNEOL, 98% 1130 (2R,3R)-(+)-2-METHYL-3- 1198 (+)-CATECHIN HYDRATE, 98% PHENYLGLYCIDOL, 97% 284 (+)-CIS-P-MENTHANE-3,8-DIOL, 1166 (2R,3R)-(+)-3-(4- 97% BROMOPHENYL)GLYCIDOL, 97% 334 (+)-ISOPULEGOL, 99% 1128 (2R,3R)-(+)-3-PHENYLGLYCIDOL, 340 (+)-LIMONEN-10-OL, 95% 97% 330 (+)-P-MENTH-1-EN-9-OL, 97%, 121 (2R,3R)-(-)-2,3-BUTANEDIOL, 97% MIXTURE OF ISOMERS 129 (2R,4R)-(-)-PENTANEDIOL, 99% 445 (+)-PERSEITOL 122 (2S,3S)-(+)-2,3-BUTANEDIOL, 99% 332 (+)-TERPINEN-4-OL, 96% 1131 (2S,3S)-(-)-2-METHYL-3- 958 (+/-)-4-FLUORO-ALPHA-(N- -
A Review on Anti-Inflammatory Activity of Monoterpenes
Molecules 2013, 18, 1227-1254; doi:10.3390/molecules18011227 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review A Review on Anti-Inflammatory Activity of Monoterpenes Rita de Cássia da Silveira e Sá 1, Luciana Nalone Andrade 2 and Damião Pergentino de Sousa 2,* 1 Department of Physiology and Pathology, Federal University of Paraíba, CP 5009, CEP 58051-970, João Pessoa, Paraíba, Brazil 2 Department of Pharmacy, Federal University of Sergipe, CEP 49100-000, São Cristóvão, Sergipe, Brazil * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 22 December 2012; in revised form: 4 January 2013 / Accepted: 5 January 2013 / Published: 18 January 2013 Abstract: Faced with the need to find new anti-inflammatory agents, great effort has been expended on the development of drugs for the treatment of inflammation. This disorder reduces the quality of life and overall average productivity, causing huge financial losses. In this review the anti-inflammatory activity of 32 bioactive monoterpenes found in essential oils is discussed. The data demonstrate the pharmacological potential of this group of natural chemicals to act as anti-inflammatory drugs. Keywords: monoterpenes; essential oils; natural products; medicinal plants; anti-inflammatory activity; inflammation; cytokines; immunomodulatory activity; asthma; allergy 1. Introduction Inflammation is a complex biological response of vascular tissues against aggressive agents such as pathogens, irritants, or damaged cells. It can be classified as either acute or chronic, and involves a cascade of biochemical events comprising the local vascular system, the immune system, and different cell types found in the injured tissue. Acute inflammation is the initial response and is characterized by the increased movement of plasma and innate immune system cells, such as neutrophils and macrophages, from the blood into the injured tissues.